Cargando…
Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids
Inadequate immunomodulatory potency of mesenchymal stem cells (MSC) may limit their therapeutic efficacy. We report glucocorticoid steroids augment MSC expression and activity of indoleamine-2,3-dioxygenase (IDO), a primary mediator of MSC immunomodulatory function. This effect depends on signaling...
Autores principales: | Ankrum, James A., Dastidar, Riddhi G., Ong, Joon Faii, Levy, Oren, Karp, Jeffrey M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982175/ https://www.ncbi.nlm.nih.gov/pubmed/24717973 http://dx.doi.org/10.1038/srep04645 |
Ejemplares similares
-
Quantification of Mesenchymal Stem Cell (MSC) Delivery to a Target Site Using In Vivo Confocal Microscopy
por: Mortensen, Luke J., et al.
Publicado: (2013) -
Controlled Inhibition of the Mesenchymal Stromal Cell Pro-inflammatory Secretome via Microparticle Engineering
por: Ranganath, Sudhir H., et al.
Publicado: (2016) -
Intracellular delivery of nitric oxide enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction
por: Hao, Tian, et al.
Publicado: (2023) -
Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies
por: Moll, Guido, et al.
Publicado: (2020) -
Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones
por: Hu, Jie, et al.
Publicado: (2010)